2009 ALVESCO (ciclesonide) Abstracts
1. Kerwin E, Andrews W, Pedinoff A. Evaluating pulmonary function with ciclesonide 80 μg twice daily or 160 μg once daily in the morning in patients with mild-to-moderate asthma not using an inhaled corticosteroid. Journal of Allergy & Clinical Immunology 2009;123(2):S262 (Abstract)
2. Nayak A, Noonan M, Andrews W, Weinstein S. Evaluating asthma control and pulmonary function with ciclesonide 80 μg twice daily or 160 μg once daily in the morning in patients who have previously received another inhaled corticosteroid. Journal of Allergy and Clinical Immunology 2009;123(2):S157 (Abstract)
3. Berger WE, Bernstein DI, Andrews W. Assessment of lung function in adults with uncontrolled mild-to-moderate asthma following treatment with ciclesonide 80 μg twice daily and 160 μg once daily. Am J Respir Crit Care Med 2009;170:A2772 (Abstract)
4. Karafilidis J, Meltzer E, Wingertzahn M, Claus R, Andrews W. Incidence of oropharyngeal and laryngeal side effects following ciclesonide treatment in adult and adolescent patients with persistent asthma. Am J Respir Crit Care Med 2009;179:A2804 (Abstract)
5. Meltzer EO, LaForce C, Korenblat P, Karafilidis J, Andrews W. The evaluation of lung function in adults with mild-to-moderate asthma following treatment with ciclesonide 80 μg twice daily or 160 μg once daily. Am J Respir Crit Care Med 2009;179:A2803 (Abstract)
6. Pedersen S, Tiesler C, Engelstatter R. Safety and tolerability of inhaled ciclesonide in children aged 6 - 11 years with asthma: The Rainbow Study. Am J Respir Crit Care Med 2009;179:A4800 (Abstract)
7. Pedersen S, Dunkel J, Engelstatter R. Efficacy of inhaled ciclesonide in children aged 6 - 11 years with asthma: The rainbow study. Am J Respir Crit Care Med 2009;179:A4825 (Abstract)
8. Pedersen S, Hirsch S, Engelstatter R. Efficacy and safety of ciclesonide MDI for the treatment of asthma in children aged 6 - 11 years - impact of spacer use. Am J Respir Crit Care Med 2009;179:A4798 (Abstract)
9. Korenblat P, Weinstein SF, Noonan M, Meltzer EO, Varga J. Evaluation of the safety and efficacy of ciclesonide 80 μg twice daily or 160 μg once daily in patients with mild-to-moderate asthma switched from a previous inhaled corticosteroid. Presented as a poster presentation at Southwest Allergy Forum, January 14 - 18, 2009 in Puerta Vallarta, Mexico. (Abstract)
10. Berger WE, Bernstein DI, Kerwin E, Pedinoff A, Varga J. Effects of ciclesonide 80 μg twice daily or 160 μg once daily in adults with mild-to-moderate asthma not using inhaled corticosteroids. Presented as a poster presentation at Southwest Allergy Forum, January 14 -18, 2009 in Puerta Vallarta, Mexico. (Abstract)
11. Korenblat P, Weinstein SF, Noonan M, Meltzer EO, Persinger R. Evaluation of the safety and efficacy of ciclesonide 80 μg twice daily or 160 μg once daily in patients with mild-to-moderate asthma switched from a previous inhaled corticosteroid. Presented as a poster presentation at Western Society of Allergy, Asthma & Immunology, January 25 - 29, 2009 in Maui, Hawaii. (Abstract)
12. Berger WE, Bernstein DI, Kerwin E, Pedinoff A, Persinger R. Effects of ciclesonide 80 μg twice daily or 160 μg once daily in adults with mild-to-moderate asthma not using inhaled corticosteroids. Presented as a poster presentation at Western Society of Allergy, Asthma & Immunology, January 25 - 29, 2009 in Maui, Hawaii. (Abstract)
13. Agertoft L, Pedersen S. Lower-leg growth rates in children with asthma during treatment with ciclesonide and fluticasone propionate. Pediatric Allergy & Immunology 2009;doi:10.1111/j.1399-3038.2009.00879.x
14. Craig T. The safety profile of ciclesonide in the treatment of persistent asthma. Allergy and Asthma Proceedings 2009;doi:10.2500/aap.2009.30.3224
15. Pedersen S, Engelstatter R, Weber HJ, Hirsch S, Barkai L, Emeryk A, Weber H, Vermeulen J. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma. Pulm Pharmacol Ther 2009;22(3):214-220.
16. Derom E, Louis R, Tiesler C, Engelstatter R, Kaufman JM, Joos GF. Eur Respir J 2009 [Epub ahead of print]
17. van den Berge M, Arshad SH, Ind PW, Magnussen H, Hamelmann E, Kanniess F, Postma DS. Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering. Respir Med 2009 [Epub ahead of print]
2008 ALVESCO (ciclesonide) Abstracts
1. Berger WE, Bernstein DI, Kerwin E, Pedinoff A. Ciclesonide 80 μg twice daily and 160 μg once daily significantly improved pulmonary function versus placebo in adults with mild-to-moderate asthma not using inhaled corticosteroids. Annals of Allergy, Asthma & Immunology 2009;102(1 suppl):A45 (Abstract)
2. Bernstein DI, Berger WE, Pedinoff A, Kerwin E. Ciclesonide 80μg twice daily and 160 μg once daily is well-tolerated in patients with mild-to-moderate asthma not using an inhaled corticosteroid. Annals of Allergy, Asthma & Immunology 2009;102(1 Suppl):A46 (Abstract)
3. Kerwin E, Pedinoff A, Berger WE, Bernstein DI. Ciclesonide 80 μg twice daily and 160 μg once daily improved measurements of asthma control versus placebo in adults with mild-to-moderate asthma not using an inhaled corticosteroid. Annals of Allergy, Asthma & Immunology 2009;102(1 Suppl): A46 (Abstract)
4. Korenblat P, Weinstein S, Noonan M, Meltzer EO. Ciclesonide 80 μg twice daily or 160 μg once daily AM significantly maintained lung function compared with placebo in patients with asthma who have previously received an inhaled corticosteroid. Annals of Allergy, Asthma & Immunology 2009;102(1 Suppl):A44 (Abstract)
5. Meltzer EO, Korenblat P, Nayak A, Weinstein S. Ciclesonide 80 μg twice daily or 160 μg once daily AM is well tolerated in adults with mild-to-moderate asthma previously receiving an inhaled corticosteroid. Annals of Allergy, Asthma & Immunology 2009;102(1 Suppl)A45 (Abstract)
6. Weinstein S, Meltzer EO, LaForce C, Korenblat P. Ciclesonide 80 μg twice daily or 160 μg once daily AM maintains variables of asthma control in adults with stable mild-to-moderate asthma previously treated with an inhaled corticosteroid. Annals of Allergy, Asthma & Immunology 2009;102(1 Suppl) A45 (Abstract)
7. Beck E, Gerber C, Engelstaetter R. Comparison of the efficacy and safety of ciclesonide with or without different spacer types in patients with asthma. AJRCCM 2008;177(Supplement):A610 (Abstract)
8. Dahl R, Trebas-Pietras E, Kuna P, Engelstaetter R. Comparison of ciclesonide 80 μg and fluticasone propionate 176 μg in patients with mild to moderate asthma. AJRCCM 2008;177(Supplement):A615 (Abstract)
9. Derom E, Louis R, Tiesler C, Engelstaetter R, Joose GF. Comparison of systemic and clinical effects of inhaled ciclesonide and fluticasone propionate in moderate to severe asthma. AJRCCM 2008;177(Supplement):A615 (Abstract)
10. Pedersen S, Weber H, Vermeulen JH, Engelstaetter R. Comparative efficacy and safety of ciclesonide 80 μg/d or 160 μg/d and fluticasone propionate 176 μg/d in children with asthma. AJRCCM 2008;177(Supplement):A710 (Abstract)
11. Ivanova J, Yu P, Birnbaum HG, Hsieh M, Seal B, Van der Molen T, Emani S, Rosiello R, Colice G. Adherence to inhaled corticosteroid use and local adverse events in persistent asthma. Value in Health 2008; 11(3):A278 (Abstract)
12. O'Day K, Salamanca-Brosig E, Regan TS, Boswell K, Nightengale B, Seal B. Asthma disease burden, evidentiary requirements, and formulary considerations among managed care and employer decision makers regarding inhaled corticosteroids (ICS). Value in Health 2008; 11(3):A282 (Abstract)
13. Taylor DC, DeLong K, Nunes K, Seal B. Cost-effectiveness of ciclesonide versus fluticasone in the treatment of patients with mild, moderate, and severe asthma. Value in Health 2008; 11(3):A271 (Abstract)
14. Yu AP, Ivanova J, Birnbaum H, Hsieh M, Seal B, Emani S, Rosiello R, Colice G. Validation of claims-based persistent asthma severity classification. Value in Health 2008; 11(3):A277 (Abstract)
15. Chylack LT, Gross GN, Pedinoff A, and the Ciclesonide Lenticular Safety Study Group. A randomized, controlled trial to investigate the effect of ciclesonide and beclomethasone dipropionate on eye lens opacity. Journal of Asthma 2008;45:893-902.
16. Nathan RA, Kanter L, Ostrom NK. Ciclesonide improves health-related quality of life in adults and adolescents with mild-to-moderate persistent asthma. Allergy Asthma Proc 2008;29:521-527.
17. Skoner DP, Maspero J, Banerji D, and the Ciclesonide Pediatric Growth Study Group. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics 2008;121(1):e1-e14.